Locations:
SearchAdvertisement
Cleveland Clinic, the University of Minnesota and University of Cambridge receive $1M grant to develop point-of-care biosensor for early detection and treatment personalization
Use of GLP-1s and improving cardiovascular health lowers risk of hematologic malignancies
Slower drug elimination from the body among females may impact safety and efficacy
Optimized responses in transplant- and CAR T-cell therapy-eligible patients
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Targeting DNMT1 shows promise in chemotherapy- and immunotherapy-resistant SCLC
Patients with a prior history of VTA are at an increased risk of subsequent incidents, despite treatment with therapeutic anticoagulation
Driving advances in cancer care
Unique molecular features found in young-onset disease
Retrospective study aims to better stratify risk of disease recurrence
Timely referral to hospice care reduces emergency room admissions
Advertisement
Advertisement